We are live on ! Find out more
CSTL icon

Castle Biosciences
CSTL

57 hedge funds and large institutions have $88.1M invested in Castle Biosciences in 2019 Q3 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

28.52% more ownership

Funds ownership: 0% → 28.52% (+29%)

Holders
57
Holders Change
+57
Holders Change %
–
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
57
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$16.5M
2
Goldman Sachs
Goldman Sachs
New York
+$6.69M
3
DCM
Driehaus Capital Management
Illinois
+$6.22M
4
WA
Wasatch Advisors
Utah
+$6.11M
5
BlackRock
BlackRock
New York
+$4.59M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NAM
1
Nexpoint Asset Management
Texas
$18.6M +$22.9M +1,030,995 New
RI
2
RTW Investments
New York
$13.5M +$16.5M +745,045 New
Goldman Sachs
3
Goldman Sachs
New York
$5.46M +$6.69M +301,722 New
DCM
4
Driehaus Capital Management
Illinois
$5.07M +$6.22M +280,401 New
WA
5
Wasatch Advisors
Utah
$4.98M +$6.11M +275,511 New
BlackRock
6
BlackRock
New York
$3.74M +$4.59M +206,946 New
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$3.3M +$4.04M +182,272 New
AIM
8
ARK Investment Management
Florida
$3M +$3.68M +166,087 New
N
9
Nuveen
North Carolina
$2.99M +$3.66M +165,306 New
Millennium Management
10
Millennium Management
New York
$2.81M +$3.45M +155,538 New
PVI
11
Pura Vida Investments
New York
$2.38M +$2.92M +131,718 New
PCM
12
Portolan Capital Management
Massachusetts
$2.26M +$2.77M +124,931 New
Vanguard Group
13
Vanguard Group
Pennsylvania
$2.04M +$2.5M +112,913 New
DM
14
Deerfield Management
New York
$1.67M +$2.05M +92,477 New
GPGA
15
Grandeur Peak Global Advisors
Utah
$1.44M +$1.76M +79,375 New
ACH
16
ArrowMark Colorado Holdings
Colorado
$1.27M +$1.55M +70,000 New
Federated Hermes
17
Federated Hermes
Pennsylvania
$1.18M +$1.44M +65,000 New
EIM
18
Essex Investment Management
Massachusetts
$963K +$1.18M +53,238 New
Northern Trust
19
Northern Trust
Illinois
$926K +$1.14M +51,197 New
ZP
20
Zimmer Partners
New York
$923K +$1.13M +51,000 New
EGI
21
EAM Global Investors
California
$795K +$975K +43,974 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$686K +$841K +37,931 New
CIP
23
Chartwell Investment Partners
Pennsylvania
$672K +$824K +37,155 New
State Street
24
State Street
Massachusetts
$652K +$799K +36,022 New
EI
25
EAM Investors
California
$615K +$754K +34,005 New
1
2 3

CSTL Hedge Fund Activity: Q3 2019 in Review

57 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Castle Biosciences (CSTL) for Q3 2019, worth a combined $88.1M.

Buyers outnumbered sellers: 57 funds opened new CSTL positions and 0 closed out — a net gain of 57 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $16.5M.

  • 57 institutional investors held Castle Biosciences (CSTL) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $88.1M of Castle Biosciences stock for Q3 2019.
  • 57 funds opened new Castle Biosciences positions in Q3 2019 and 0 closed out, a net change of +57 holders.
  • The largest Castle Biosciences buyer in Q3 2019 was RTW Investments, an estimated $16.5M added.

Based on aggregated 13F filings for Q3 2019.